-
1 Comment
48North Cannabis Corp is currently in a long term downtrend where the price is trading 14.6% below its 200 day moving average.
From a valuation standpoint, the stock is 99.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.9.
48North Cannabis Corp's total revenue rose by 271.7% to $6M since the same quarter in the previous year.
Its net income has dropped by 16.0% to $-7M since the same quarter in the previous year.
Finally, its free cash flow grew by 47.3% to $-4M since the same quarter in the previous year.
Based on the above factors, 48North Cannabis Corp gets an overall score of 3/5.
ISIN | CA34978F1036 |
---|---|
Industry | Drug Manufacturers - Specialty & Generic |
Sector | Healthcare |
Exchange | V |
CurrencyCode | CAD |
Market Cap | 16M |
---|---|
Dividend Yield | 0.0% |
Target Price | 0.35 |
Beta | 1.29 |
PE Ratio | None |
48North Cannabis Corp. operates as a cannabis company in the health and wellness market in Canada. The company offers bath salts, intimacy oils, flowers, pre-rolls, body cream and oil, vapes, pressed hash, and accessories under 48North, Apothecanna, First Harvest, Avitas, F8, Trail Mix, and Latitude brands. It also provides LAT, a publication and creative platform that empowers women to connect, engage, and learn through their experiences with cannabis. 48North Cannabis Corp. is headquartered in Toronto, Canada. As of September 1, 2021, 48North Cannabis Corp. operates as a subsidiary of HEXO Corp.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for NRTH.V using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025